SCHEMBL23818486

SCHEMBL23818486

CO[C@](C#N)(COCN[C@@H](C)C(=O)OC1CCCCC1)[C@@H](O)[C@@H](O)c1ccc2c(N)ncnn12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26291726 1.00 — —
SCHEMBL23818619 0.98 — —
SCHEMBL26290880 0.93 JAK2 (0.30) —
SCHEMBL26295044 0.93 — —
SCHEMBL26297926 0.93 — —
SCHEMBL23818968 0.91 — —
SCHEMBL26295061 0.91 — —
SCHEMBL23818876 0.90 EGLN2 (0.32) —
SCHEMBL23818962 0.90 EGLN2 (0.32) —
SCHEMBL23818946 0.88 RIPK1 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11767337-B2 Antiviral compounds GILEAD SCIENCES, INC. (US) 2023-09-26 — — US disclosed
US-20230295201-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. 2023-09-21 — — US disclosed
US-20210284669-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. 2021-09-16 — — US disclosed
Send feedback